首页 | 本学科首页   官方微博 | 高级检索  
     


Different natural courses of chronic hepatitis B with genotypes B and C after the fourth decade of life
Authors:Maeshiro Tatsuji  Arakaki Shingo  Watanabe Takako  Aoyama Hajime  Shiroma Joji  Yamashiro Tsuyoshi  Hirata Tetsuo  Hokama Akira  Kinjo Fukunori  Nakayoshi Tomofumi  Nakayoshi Tomokuni  Mizokami Masashi  Fujita Jiro  Sakugawa Hiroshi
Affiliation:1. Control and Prevention of Infectious Disease (First Department of Internal Medicine), Department of Medicine and Therapeutics, Faculty of Medicine, University of the Ryukyus,Okinawa, Japan
2. Department of Blood transfusion medicine,Ryukyu University Hospital, Okinawa, Japan
3. Department of Endoscopy, Ryukyu University Hospital, Okinawa, Japan
4. Department of Internal Medicine,Tomishiro Central Hospital, Okinawa, Japan
5. Department of Internal Medicine, Heart Life Hospital, Okinawa, Japan
6. Clinical Molecular Informative Medicine,Nagoya City University Graduate School of Medical Science,Nagoya, Japan
Abstract:AIM: To investigate the different impact of genotypes B and C on the development of liver cirrhosis (LC) among different age groups of patients with chronic hepatitis B (CH-B). METHODS: We examined the outcome of 121 patients with CH-B, divided by age and genotype. Univariate analyses were used to compare different groups. The Cox proportional hazard model was employed to evaluate factors affecting the development of LC. RESULTS: In patients < 30 years old, there were no significant predictors for development of LC. However, in patients > or = 30 years old, genotype C was the only significant predictor. In the genotype C group, 8 of 12 patients who progressed to LC were 30-49 years old at initial diagnosis of chronic hepatitis (7 patients were positive for HBeAg). In the genotype B group, 4 of 8 patients who developed LC were > or = 50 years old at initial diagnosis and were HBeAg-negative. CONCLUSION: The rate of development of LC was comparable in patients infected with genotypes B and C when CH-B occurred at < 30 years old. However, CH-B patients infected with genotype C showed poor prognosis if they were 30-49 years old and were positive for HBeAg. Age-specific natural course of CH-B should be considered when patients with CH-B are treated with antiviral drugs.
Keywords:Hepatitis B,chronic  Hepatitis B virus  Hepatitis B e antigen  Genotypes  Molecular epidemiology
本文献已被 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号